APA (7th ed.) Citation

Strand, V., Mease, P. J., Soriano, E. R., Kishimoto, M., Salvarani, C., Saffore, C. D., . . . Gladman, D. D. (2021). Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1. Rheumatology & Therapy, 8(4), 1789. https://doi.org/10.1007/s40744-021-00379-9

Chicago Style (17th ed.) Citation

Strand, Vibeke, et al. "Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1." Rheumatology & Therapy 8, no. 4 (2021): 1789. https://doi.org/10.1007/s40744-021-00379-9.

MLA (9th ed.) Citation

Strand, Vibeke, et al. "Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1." Rheumatology & Therapy, vol. 8, no. 4, 2021, p. 1789, https://doi.org/10.1007/s40744-021-00379-9.